PF-429242 exhibits anticancer activity in hepatocellular carcinoma cells via FOXO1-dependent autophagic cell death and IGFBP1-dependent anti-survival signaling.

Jiunn-Chang Lin(Mackay Memorial Hospital), Pei‐Ming Yang(Wan Fang Hospital)

PubMed

January 1, 2023

Cited by 10

Related Papers

Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells

|Biomolecules|2020|64

A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine

|Scientific Reports|2014|47

Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner

|Biomolecules|2020|41

In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells

|Biomolecules|2019|32

Long Non-Coding RNA MIR31HG Promotes the Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma Cells

|International Journal of Molecular Sciences|2022|13